FindMyRecallSubscribe
Class I: serious health riskOngoing

Baxter Healthcare Cefazolin in Dextrose Recall

Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag…

Baxter Healthcare Corporation · Deerfield, IL

Risk level
Class I
Reported by FDA
Aug 19, 2026
Recall ID
D-0787-2026
Check your lot numberHow we source this data

Summary

Baxter Healthcare recalled Cefazolin in Dextrose starting Jul 24, 2026. The FDA classified it as Class I (serious health risk) and published enforcement report D-0787-2026 on Aug 19, 2026. Reason: Presence of Particulate Matter. Status: Ongoing.

Why it was recalled

Presence of Particulate Matter

Product description

Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-3508-41.

Lot numbers, UPCs & expiration codes

Lot # LD175708, Exp Date: 14-Feb-2027.

Where it was sold

US Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0787-2026
Classification
Class I
Status
Ongoing
Recall initiated
Jul 24, 2026
FDA report date
Aug 19, 2026
Quantity
19,032 bags
Recall type
Voluntary: Firm initiated
Recalling firm
Baxter Healthcare Corporation

Original FDA data

Every field from FDA enforcement report D-0787-2026, exactly as published.

Show all FDA fields
City
Deerfield
State
IL
Status
Ongoing
Country
United States
Event ID
99463
Address
1 Baxter Pkwy
Code information
Lot # LD175708, Exp Date: 14-Feb-2027.
Postal code
60015-4625
Report date
Aug 19, 2026
Product type
Drugs
Recall number
D-0787-2026
Classification
Class I
Recalling firm
Baxter Healthcare Corporation
Product quantity
19,032 bags
Reason for recall
Presence of Particulate Matter
Voluntary / mandated
Voluntary: Firm initiated
Product description
Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-3508-41.
Distribution pattern
US Nationwide.
Recall initiation date
Jul 24, 2026
Initial firm notification
Letter
Center classification date
Aug 21, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0787-2026, published Aug 19, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls